[Rhabdomyolysis in severe acute asthma].
Awab
A
A
Alilou
M
M
El Moussaoui
R
R
El Hijri
A
A
Azzouzi
A
A
D000138:Acidosis / Q000209:etiology; D000208:Acute Disease; D000328:Adult; D000420:Albuterol / Q000627:therapeutic use; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use; D001249:Asthma / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D015415:Biomarkers; D003131:Combined Modality Therapy; D052283:Creatine Kinase, MM Form / Q000097:blood; D005260:Female; D005283:Fentanyl / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000031:analogs & derivatives / Q000627:therapeutic use; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D000860:Hypoxia / Q000209:etiology; D008297:Male; D008874:Midazolam / Q000627:therapeutic use; D012121:Respiration, Artificial; D012132:Respiratory Muscles / Q000503:physiopathology; D012206:Rhabdomyolysis / Q000097:blood / Q000209:etiology*
D018927:Anti-Asthmatic Agents; D015415:Biomarkers; D006993:Hypnotics and Sedatives; D052283:Creatine Kinase, MM Form; C007133:hydrocortisone hemisuccinate; D000420:Albuterol; D008874:Midazolam; D005283:Fentanyl; D006854:Hydrocortisone